oxaluria

(redirected from hyperoxaluria)
Also found in: Medical, Wikipedia.

oxaluria

[‚äk·səl′yu̇r·ē·ə]
(medicine)
The presence of oxalic acid or oxalates in the urine.
References in periodicals archive ?
In a series of presentations at the 12th International Workshop on Primary Hyperoxaluria for Professionals, Patients and Families in Tenerife, Spain from July 14-16, 2017, Dicerna scientists presented research from animal models demonstrating how DCR-PHXC inhibits the lactate dehydrogenase A gene, which Dicerna has identified as potentially being an optimal therapeutic target in patients with PH, a group of severe, rare, inherited disorders of the liver that often result in kidney failure.
M2 EQUITYBITES-September 3, 2015-Dicerna Pharmaceuticals files IND application with the US FDA for therapeutic candidate DCR-PH1 for treating primary hyperoxaluria type 1
The diabetic group had a statistically significant increase in their average oxalate excretion and a significantly higher percentage of patients had hyperoxaluria and hypernatriuria.
Since Stephen was diagnosed with primary hyperoxaluria, a very rare disease caused by a missing liver enzyme, Kerry has devoted herself to caring for him.
Importance of mild hyperoxaluria in the pathogenesis of urolithiasis-new evidence from studies in the Arabian Peninsula.
net 1,2,3,5,6,9 HYPERLIPODEMA See: Autoimmune Disorders HYPEROXALURIA See: Oxalosis & Hyperoxaluria HYPERTELORISM/ HYPOSPADIUS SYNDROMES See: Opitz Syndrome HYPERTHERMIA OF ANESTHESIA See: Malignant Hyperthermia HYPERTHYROID MYOPATHY See: Muscular Dystrophy; Thyroid Disorder HYPERURICEMIA-CHOREOATH ETOSIS-SELF-MUTILATION SYNDROME See: Lesch-Nyhan Disease HYPERURICEMIA, HEREDITARY See: Lesch-Nyhan Disease HYPODONTIA AND NAIL DYSGENESIS See: Ectodermal Dysplasias HYPOERYTHEMIA, PROGRESSIVE See: Anemia, Aplastic HYPOGAMMAGLOBULINEMIA See: Immune Disorders HYPOMELANOSIS OF ITO See: Ectodermal Dysplasias; Epilepsy; Incontinentia Pigmenti; Vitiligo HYPOMYELINATION See: Myelin Disorders HYPOPARATHYROIDISM See also: Thyroid Disorders Hypoparathyroidism Newsletter 2835 Salmon St.
STOCKHOLM, Sweden -- OxThera today announced that all 42 patients have been enrolled in their pivotal phase II/III study using Oxabact[TM] for the treatment of Primary Hyperoxaluria.
The product is intended to treat primary hyperoxaluria type 1, a severe, rare, inherited disorder of the liver.
Doctors in Newcastle have just diagnosed Stephen with a rare life-threatening liver condition called primary hyperoxaluria.
Altus plans to report data from the Phase 1 trial of ALTU-237 in hyperoxaluria during the second quarter of 2008.
The license agreement has been signed for Dicerna to use Tekmira's proprietary lipid nanoparticle technology for delivery of DCR-PH1, Dicerna's investigational product candidate for primary hyperoxaluria type 1, a rare, inherited liver disorder that often results in kidney failure, and for which there are no approved therapies.